A Focus on Human iPSC-Derived Organoid Models

Andrew McDonald,Jan Wijnholds
DOI: https://doi.org/10.3390/ijms25052887
IF: 5.6
2024-03-02
International Journal of Molecular Sciences
Abstract:The human photoreceptor function is dependent on a highly specialised cilium. Perturbation of cilial function can often lead to death of the photoreceptor and loss of vision. Retinal ciliopathies are a genetically diverse range of inherited retinal disorders affecting aspects of the photoreceptor cilium. Despite advances in the understanding of retinal ciliopathies utilising animal disease models, they can often lack the ability to accurately mimic the observed patient phenotype, possibly due to structural and functional deviations from the human retina. Human-induced pluripotent stem cells (hiPSCs) can be utilised to generate an alternative disease model, the 3D retinal organoid, which contains all major retinal cell types including photoreceptors complete with cilial structures. These retinal organoids facilitate the study of disease mechanisms and potential therapies in a human-derived system. Three-dimensional retinal organoids are still a developing technology, and despite impressive progress, several limitations remain. This review will discuss the state of hiPSC-derived retinal organoid technology for accurately modelling prominent retinal ciliopathies related to genes, including RPGR, CEP290, MYO7A, and USH2A. Additionally, we will discuss the development of novel gene therapy approaches targeting retinal ciliopathies, including the delivery of large genes and gene-editing techniques.
biochemistry & molecular biology,chemistry, multidisciplinary
What problem does this paper attempt to address?
The problems that this paper attempts to solve mainly focus on the research of Retinal Ciliopathies and their potential gene therapies. Specifically, the author is concerned with how to use the three - dimensional retinal organoid model derived from human - induced pluripotent stem cells (hiPSCs) to more accurately simulate these diseases and explore new treatment methods. The following are the specific problems that the paper attempts to solve: 1. **Accurately model Retinal Ciliopathies**: - **Limitations of animal models**: Although animal models have made certain progress in the research of Retinal Ciliopathies, they are often unable to fully simulate the phenotypes of patients because the retinal structure and function of animals are different from those of humans. - **Advantages of hiPSCs - derived retinal organoids**: Human - induced pluripotent stem cells can generate three - dimensional retinal organoids containing all major retinal cell types. These organoids can more accurately reflect the structure and function of the human retina, thus better simulating Retinal Ciliopathies. 2. **Study disease mechanisms**: - **Effects of gene mutations**: The paper explores the effects of different gene mutations (such as RPGR, CEP290, MYO7A and USH2A) on the function of retinal cilia, and how these mutations lead to the death of photoreceptor cells and vision loss. - **Protein localization and function**: By analyzing the protein localization and expression in organoids, researchers can better understand how these mutations affect the formation and function of cilia. 3. **Develop new gene therapies**: - **Gene delivery technologies**: The paper discusses how to use adeno - associated virus (AAV) vectors to deliver large genes, and the application of gene - editing technologies such as CRISPR/Cas9 in the treatment of Retinal Ciliopathies. - **Optimize treatment strategies**: For different gene mutations, researchers need to develop and optimize gene therapies suitable for human retinal cells to improve the treatment effect. 4. **Evaluate the effectiveness of the organoid model**: - **Morphological and functional evaluation**: The paper introduces how to evaluate the morphological characteristics and functions of retinal organoids by methods such as immunohistochemistry and single - cell RNA sequencing to verify their effectiveness as disease models. - **Limitations and future directions**: Although retinal organoid technology has made significant progress, there are still some limitations, such as immature outer segment structures, high costs, and complex operations. The paper also discusses how to overcome these limitations by improving culture conditions and techniques. In conclusion, this paper aims to more accurately simulate Retinal Ciliopathies through the retinal organoid model derived from human - induced pluripotent stem cells and explore effective gene - treatment strategies, thereby providing better treatment options for patients.